Barrington Research Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its target price dropped by equities research analysts at Barrington Research from $125.00 to $110.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s target price points to a potential upside of 35.58% from the company’s current price.

A number of other equities analysts have also recently issued reports on the company. Barclays reduced their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. BTIG Research lowered their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target on the stock. in a research report on Friday, January 9th. Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research note on Thursday, February 19th. Finally, Royal Bank Of Canada decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average target price of $110.36.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $81.13 on Wednesday. The firm has a fifty day moving average of $80.59 and a two-hundred day moving average of $90.13. The company has a debt-to-equity ratio of 0.45, a quick ratio of 4.13 and a current ratio of 3.27. The stock has a market capitalization of $6.85 billion, a price-to-earnings ratio of 32.98, a PEG ratio of 0.99 and a beta of 0.26. HealthEquity has a 52 week low of $72.76 and a 52 week high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The business had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. HealthEquity’s quarterly revenue was up 7.3% compared to the same quarter last year. As a group, equities research analysts predict that HealthEquity will post 2.32 EPS for the current year.

Institutional Investors Weigh In On HealthEquity

Hedge funds have recently modified their holdings of the business. Acumen Wealth Advisors LLC bought a new position in shares of HealthEquity during the 4th quarter valued at about $27,000. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd increased its stake in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares in the last quarter. True Wealth Design LLC increased its stake in HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after purchasing an additional 317 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after buying an additional 146 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Key HealthEquity News

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Deutsche Bank raised its price target to $128 and kept a “buy” rating — the new target implies ~57.8% upside from the current price, signaling strong analyst conviction. Deutsche Bank price target raise
• Positive Sentiment: Q4 2026 results and call highlighted record HSA growth, revenue and EPS beats (quarterly revenue and EPS modestly ahead of consensus), supporting continued top-line momentum and cash economics. HQY Q4 2026 Earnings Call Highlights
• Positive Sentiment: Seeking Alpha published a rating upgrade citing improved cash economics, which reinforces buy-side theses around margin expansion and free cash flow improvement. Seeking Alpha upgrade
• Positive Sentiment: Press roundup / analyst commentary piece flagged HealthEquity among bullish healthcare names, adding to positive market narrative. Globe & Mail analyst roundup
• Neutral Sentiment: Full Q4 earnings call transcripts were posted across outlets (MSN, Seeking Alpha, Yahoo) — useful for digging into management commentary on enrollment, revenue cadence and margin drivers but not new information beyond the released results. MSN earnings transcript Seeking Alpha earnings transcript
• Negative Sentiment: Barrington Research trimmed its price target from $125 to $110 (still “outperform”), reducing upside assumptions to ~35.6% and signaling slightly less bullishness from one coverage shop. Barrington price target update
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but maintained an “overweight” rating, trimming some upside expectations while staying constructive (~51.6% implied upside). JPMorgan price target update
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”), tightening the analyst target band and signaling a more cautious near-term view. RBC price target update

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.